Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2000 Jul;7(4):652-7.
doi: 10.1128/CDLI.7.4.652-657.2000.

Comparison of two recombinant major outer membrane proteins of the human granulocytic ehrlichiosis agent for use in an enzyme-linked immunosorbent assay

Affiliations
Comparative Study

Comparison of two recombinant major outer membrane proteins of the human granulocytic ehrlichiosis agent for use in an enzyme-linked immunosorbent assay

T Tajima et al. Clin Diagn Lab Immunol. 2000 Jul.

Abstract

Enzyme-linked immunosorbent assay (ELISA) for human granulocytic ehrlichiosis (HGE) using two different recombinant P44 proteins (rP44 and rP44-2hv) of the HGE agent as antigens was evaluated. Sera from a total of 72 healthy humans both from regions where HGE is nonendemic and regions where HGE is endemic were used as negative controls to determine the cutoff value for ELISA. Sera from a total of 14 patients (nine from whom the HGE agent was isolated and five who were HGE-PCR positive) were used as positive controls. One hundred nine sera from 72 patients in an area where HGE is endemic who were suspected of having HGE were examined by ELISA and indirect immunofluorescence assay (IFA). All IFA-negative sera were negative by both ELISAs. Of 39 sera that were IFA positive, 35 and 27 were positive by ELISA using rP44 and rP44-2hv, respectively, indicating that the use of rP44 is more sensitive. Western blot analysis of the four rP44-ELISA-negative IFA-positive sera using whole HGE agent as antigen suggests that these four sera were false IFA positive. There was no difference in results with or without the preabsorption of sera with Escherichia coli or with or without the cleavage of the fused protein derived from the vector. There was a significant positive correlation between IFA titers and optical densities of ELISAs. Four Ehrlichia chaffeensis-positive and 10 Borrelia burgdorferi-positive sera were negative by ELISA. However, two Babesia microti-positive sera showed strong cross-reactivity to the fused vector protein, which was eliminated after cleavage of the protein. Thus, ELISA using rP44 nonfusion protein would provide a simple, specific, and objective HGE serologic test which can be easily automated.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Western blot analysis of patient sera by using the native HGE agent as an antigen. Samples subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis consisted of 10 μg of purified whole-cell preparation of HGE agent. The protein was transferred to nitrocellulose membrane and was incubated with a 1:100 dilution of sera (B66, J14, B20, A30, B02, B14, MoAb, or J01). Numbers at the left are molecular mass standards (in kilodaltons) based on the broad-range prestained standards (Bio-Rad Laboratories, Richmond, Calif.).
FIG. 2
FIG. 2
Correlation between IFA titers and ODs of ELISA by using EK-rP44 as an antigen. Each circle represents one sample. The rho value calculated by Spearman's rank correlation was 0.740 (P < 0.001) (n = 181).

References

    1. Aguero-Rosenfeld M E, Horowitz H W, Wormser G P, McKenna D F, Nowakowski J, Munoz J, Dumler J S. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996;125:904–908. - PubMed
    1. Bakken J S, Dumler J S, Chen S M, Eckman M R, van Etta L L, Walker D H. Human granulocytic ehrlichiosis in the upper Midwest United States: a new species emerging? JAMA. 1994;272:212–218. - PubMed
    1. Bakken J S, Krueth J, Wilson-Nordskog C, Tilden R L, Asanovich K, Dumler J S. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1996;275:199–205. - PubMed
    1. Brouqui P. Ehrlichiosis in Europe. In: Raoult D, Brouqui P, editors. Rickettsiae and rickettsial diseases at the turn of the third millenium. Paris, France: Elsevier; 1999. pp. 220–232.
    1. Chen S-M, Dumler J S, Bakken J S, Walker D H. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol. 1994;32:589–595. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources